cobas® eplex respiratory pathogen panel 3

Bringing customization to the syndromic respiratory panel on the cobas® eplex and evolving the respiratory continuum of care
IVD For in vitro diagnostic use.

cobas eplex Respiratory Pathogen Panel 3
cobas® eplex Respiratory Pathogen Panel 3

The cobas® eplex respiratory pathogen panel 3 (RP3) is a qualitative nucleic acid multiplex in vitro diagnostic test intended for use by laboratory professionals on the cobas® eplex system for simultaneous detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs in viral transport media obtained from patients suspected of respiratory tract infections.

Key features of the cobas® eplex RP3 panel:

  • Less than one minute of hands-on time
  • Now includes Bordetella pertussis
  • Overall product optimization
  • Improved influenza virus and SARS-CoV-2 inclusivity
  • Compatible with flexible syndromic testing (a new feature of the cobas® eplex system software that allows users to customize panel configurations)
cobas eplex Respiratory Pathogen Panel 2

Broad-spectrum coverage: Detect co-infections in a single run

The cobas® eplex RP3 Panel identifies and detects more than 19 of the most common respiratory viruses and bacteria causing respiratory illness in about 90 minutes, allowing clinicians to make informed patient care decisions faster. Rapid diagnosis may be important for people who are more likely to become seriously ill from complications or require hospitalization, such as young children, adults 65 and older, pregnant women and those with compromised immune systems.1

Automated syndromic testing for respiratory surges

During respiratory season when infections tend to peak, influenza is often the first virus people think of. In the U.S., CDC estimates 6,512 deaths from influenza annually.2 Other viruses, such as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), are also more prevalent at certain times of the year, while others, like adenovirus and rhinovirus, are common year-round.3,4

Why use syndromic testing?

By detecting the most common pathogens that cause disease together on a single rapid test, with a single patient sample, the right therapeutic can be prescribed within hours.

Comprehensive testing with a syndromic respiratory panel means that clinicians get the information they need to help make an informed decision. This can mean that a patient avoids unnecessary antimicrobial treatment, and the possible adverse side effects that may be caused by them. Reducing unnecessary use of antimicrobials also aids in antimicrobial stewardship.

cobas® eplex Respiratory Pathogen Panel 3, FDA 
Adenovirus
Enterovirus/rhinovirus
Coronavirus (229E, HKU1, NL63, OC43)
SARS-CoV-2
Human metapneumovirus
Human parainfluenza 1
Human parainfluenza 2
Human parainfluenza 3
Human parainfluenza 4
Influenza A virus
Influenza A virus H1
Influenza A virus H1-2009
Influenza A virus H3
Influenza B virus
RSV A
RSV B
Bordetella pertussis
Chlamydia pneumoniae
Mycoplasma pneumoniae
cobas eplex System

cobas® eplex System

True sample-to-answer solution

The cobas® eplex System integrates the entire process from order-to-report to better realize the patient and laboratory benefits of rapid, multiplex molecular diagnostics.

Use left and right arrow keys to scroll between the tabs

Overview

Ordering information

error errorMessage
Sorry, we couldn't find the content you are looking for
Please try again later

Compatible products

No products found for this filter.
No products found for this filter.

Contact us

Do you have any questions about this product or service? We’re here to help. Fill out the form to have a Roche representative contact you.

References

  1. CDC Respiratory Illness site: https://www.cdc.gov/respiratory-viruses/risk-factors/index.html. Accessed November 2026.
  2. CDC Data on influenza, https://www.cdc.gov/nchs/fastats/flu.htm. Accessed November 2026.
  3. Ronald B. Turner, Rhinovirus: More than Just a Common Cold Virus, The Journal of Infectious Diseases, Volume 195, Issue 6, 15 March 2007, Pages 765–766, https://doi.org/10.1086/511829
  4. Centers for Disease Control and Prevention. The National Respiratory and Enteric Virus Surveillance System (NREVSS). https://www.cdc.gov/surveillance/nrevss/index.html. Accessed April 2023.